Get the Stockscreener App
11.50
0.61%
0.07
After Hours:
11.00
-0.50
-4.35%
Replimune Group Inc Stock (REPL) Latest News
Arizona State Retirement System Invests $156,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Financial Metrics Check: Replimune Group Inc (REPL)’s Ratios for Trailing Twelve Months - The Dwinnex
Replimune Group Appoints New Director, Grants Stock Options By Investing.com - Investing.com Australia
Replimune Group Appoints New Director, Grants Stock Options - Investing.com
Replimune Group Appoints Michael Goller To Board, Increases Board Size To Ten -March 07, 2025 at 05:04 pm EST - Marketscreener.com
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 04:11 pm EST - Marketscreener.com
Rhumbline Advisers Grows Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs - Bain Capital
New York State Common Retirement Fund Purchases 31,231 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
JPMorgan Chase & Co. Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat
Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World
Replimune Group (NASDAQ:REPL) Stock Price Up 6.1%What's Next? - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.29 Average Price Target from Brokerages - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Short Interest Update - MarketBeat
Replimune's SWOT analysis: oncolytic immunotherapy stock poised for FDA approval - Investing.com UK
Possible Bearish Signals With Replimune Group Insiders Disposing Stock - Simply Wall St
Leerink Partnrs Predicts Weaker Earnings for Replimune Group - Defense World
FY2025 EPS Estimates for Replimune Group Lowered by Wedbush - MarketBeat
Replimune Group (NASDAQ:REPL) Announces Quarterly Earnings Results - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Replimune Group (NASDAQ:REPL) Stock - MarketBeat
Replimune stock target raised to $22 at H.C. Wainwright - MSN
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN
Replimune stock target raised to $22 at H.C. Wainwright By Investing.com - Investing.com Australia
Replimune: A Misunderstood Contender In Oncolytics (NASDAQ:REPL) - Seeking Alpha
Wedbush Raises Replimune Group's Price Target to $19 From $16, Keeps Outperform Rating - Marketscreener.com
Replimune Group Inc. (REPL) reports earnings - Quartz
Replimune Group, Inc. SEC 10-Q Report - TradingView
Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
FDA Fast-Tracks Replimune's Melanoma Treatment as Cash Reserves Hit $536M in Q3 Report - StockTitan
Top Wealth Group Holding Ltd (TWG)’s financial ratios: A comprehensive overview - The Dwinnex
Metric Analysis: Nvni Group Ltd (NVNI)’s Key Ratios in the Limelight - The Dwinnex
Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
How to Take Advantage of moves in (REPL) - Stock Traders Daily
Replimune's Strategic Move: $14.25 Stock Options Package Secures Top Talent - StockTitan
Replimune Group (REPL) Expected to Announce Earnings on Thursday - Defense World
Holdings of Replimune Group Inc (REPL) are aligned with the stars - SETE News
SG Americas Securities LLC Acquires 3,374 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Was there any good news for Replimune Group Inc (REPL) stock in the last session? - US Post News
Upward Trajectory: Replimune Group Inc (REPL) Posts a Slidee, Closing at 13.71 - The Dwinnex
Vanguard Group Inc's Strategic Acquisition of Replimune Group In - GuruFocus.com
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):